Suchergebnisse - "Romach, Myroslava K"

PubPharm (41)

1

Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?

enthalten in: Clinical pharmacology in drug development | 2024

von Sellers, E. | Romach, M.

CommentOn: Clin Pharmacol Drug Dev. 2024 Jan;13(1):58-69. - PMID 37496452

2

Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?

enthalten in: Clinical Pharmacology in Drug Development | 2024

von Sellers, E. | Romach, M.

3

Psychedelics : Science sabotaged by Social Media

enthalten in: Neuropharmacology | 2023

von Sellers, E. | Romach, M.

4

Studies with psychedelic drugs in human volunteers

enthalten in: Neuropharmacology | 2018

von Sellers, E. | Romach, M. | Leiderman, D.

5

Categorization of Abuse Potential-Related Adverse Events

enthalten in: Clinical pharmacology in drug development | 2018

von Sellers, E. | Romach, M.

6

Building Healthcare Capacity in Pediatric Neurosurgery and Psychiatry in a Post-Soviet System : Ukraine

enthalten in: World neurosurgery | 2018

von Romach, M. | Rutka, J.

7

Categorization of Abuse Potential–Related Adverse Events

enthalten in: Clinical Pharmacology in Drug Development | 2018

von Sellers, E. | Romach, M.

8

Human abuse liability evaluation of CNS stimulant drugs

enthalten in: Neuropharmacology | 2014

von Romach, M. | Schoedel, K. | Sellers, E.

9

Human abuse liability evaluation of CNS stimulant drugs

enthalten in: Neuropharmacology | 2014

von Romach, M. | Schoedel, K. | Sellers, E.

10

Brain Network Activation (BNA) reveals scopolamine-induced impairment of visual working memory

enthalten in: Journal of molecular neuroscience : MN | 2014

von Reches, A. | Levy-Cooperman, N. | Laufer, I. | +9

1
2
3
4
5
Nächster »
[5]